Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
The impact of GLP-1 RAs on bone health has been explored in multiple clinical studies, though findings are inconsistent
Usual wellness tipshydration, light activity, fibermay help you feel better if youre nauseated or constipated, but they dont accelerate pharmacokinetic elimination
Where Tirzepatide combines GLP-1 and GIP receptor agonism, and Mazdutide combines GLP-1 and glucagon receptor agonism, Retatrutide brings all three pathways together in a single molecule
In contrast, a lack of sleep raises cortisol and inflammation, decreasing GLP-1 secretion and increasing hungermaking consistent, restorative sleep imperative for maintaining a healthy weight
Start your consultation today.